Found: 343
Select item for more details and to access through your institution.
[<sup>68</sup>Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 9, p. 2684, doi. 10.1007/s00259-024-06735-5
- By:
- Publication type:
- Article
A Targetable Receptor Tyrosine Kinase in Metastatic Pheochromocytoma and Paraganglioma: A Future Journey for Anlotinib?
- Published in:
- Journal of the Endocrine Society, 2024, v. 8, n. 7, p. 1, doi. 10.1210/jendso/bvae092
- By:
- Publication type:
- Article
Imaging of Pheochromocytomas and Paragangliomas.
- Published in:
- Endocrine Reviews, 2024, v. 45, n. 3, p. 414, doi. 10.1210/endrev/bnae001
- By:
- Publication type:
- Article
A Rare Cyclic Cushing Syndrome Mystery Illustrates Diagnostic Principles.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 6, p. 1, doi. 10.1210/jcemcr/luae094
- By:
- Publication type:
- Article
Niche for polyamine inhibition in treatment of metastatic pheochromocytoma and paraganglioma.
- Published in:
- European Journal of Clinical Investigation, 2024, v. 54, n. 5, p. 1, doi. 10.1111/eci.14162
- By:
- Publication type:
- Article
rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells.
- Published in:
- Advanced Science, 2024, v. 11, n. 14, p. 1, doi. 10.1002/advs.202308280
- By:
- Publication type:
- Article
Managing Catecholamine Release Syndrome During and Following Lu-177-DOTATATE in High-Risk Pheochromocytoma Patients.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 4, p. 1, doi. 10.1210/jcemcr/luae049
- By:
- Publication type:
- Article
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-51804-2
- By:
- Publication type:
- Article
Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 2, p. 471, doi. 10.1210/clinem/dgad515
- By:
- Publication type:
- Article
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44563-7
- By:
- Publication type:
- Article
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma.
- Published in:
- Frontiers in Endocrinology, 2023, p. 01, doi. 10.3389/fendo.2023.1273093
- By:
- Publication type:
- Article
High incidence of occult familial SDHD cases amongst Czech patients with head and neck paragangliomas.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1278175
- By:
- Publication type:
- Article
PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5199, doi. 10.3390/cancers15215199
- By:
- Publication type:
- Article
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study.
- Published in:
- European Journal of Endocrinology, 2023, v. 189, n. 5, p. 546, doi. 10.1093/ejendo/lvad146
- By:
- Publication type:
- Article
Immune Landscape of Pheochromocytoma and Paraganglioma: A Potentially Novel Avenue for Prognostic Reclassification?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 11, p. e1456, doi. 10.1210/clinem/dgad192
- By:
- Publication type:
- Article
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [<sup>177</sup>Lu]Lu-DOTA-TATE therapy.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1275813
- By:
- Publication type:
- Article
Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization.
- Published in:
- Clinical Proteomics, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12014-023-09428-7
- By:
- Publication type:
- Article
Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3155, doi. 10.1007/s00259-023-06261-w
- By:
- Publication type:
- Article
rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02744-8
- By:
- Publication type:
- Article
Editorial: Pediatric adrenal neoplasms.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1227835
- By:
- Publication type:
- Article
Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1030412
- By:
- Publication type:
- Article
Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1030412
- By:
- Publication type:
- Article
The Emergence of Somatostatin Antagonist-Based Theranostics: Paving the Road Toward Another Success?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 682, doi. 10.2967/jnumed.123.265406
- By:
- Publication type:
- Article
Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 2, p. 397, doi. 10.1210/clinem/dgac563
- By:
- Publication type:
- Article
Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1081783
- By:
- Publication type:
- Article
Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis.
- Published in:
- Endocrine (1355008X), 2023, v. 79, n. 1, p. 171, doi. 10.1007/s12020-022-03218-1
- By:
- Publication type:
- Article
Preclinical Models of Neuroendocrine Neoplasia.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5646, doi. 10.3390/cancers14225646
- By:
- Publication type:
- Article
PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1045517
- By:
- Publication type:
- Article
Determination of FGF23 Levels for the Diagnosis of FGF23‐Mediated Hypophosphatemia.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 11, p. 2174, doi. 10.1002/jbmr.4702
- By:
- Publication type:
- Article
Targeted Therapies in Pheochromocytoma and Paraganglioma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 11, p. 2963, doi. 10.1210/clinem/dgac471
- By:
- Publication type:
- Article
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34011-3
- By:
- Publication type:
- Article
Chronic Ethanol Consumption Alters Presynaptic Regulation of Dorsal Striatal Dopamine Release in C57BL/6J Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 10994, doi. 10.3390/ijms231910994
- By:
- Publication type:
- Article
Choice is good at times: the emergence of [<sup>64</sup>Cu]Cu-DOTATATE based somatostatin receptor imaging in the era of [<sup>68</sup>Ga]Ga-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264183
- By:
- Publication type:
- Article
Functional Imaging of Neuroendocrine Tumors: Stacking the Odds in a Patient’s Favor.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 9, p. e3953, doi. 10.1210/clinem/dgac298
- By:
- Publication type:
- Article
Choice is good at times: the emergence of [<sup>64</sup>Cu]Cu-DOTATATE based somatostatin receptor imaging in the era of [<sup>68</sup>Ga]Ga-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264183
- By:
- Publication type:
- Article
Performances of Functional and Anatomic Imaging Modalities in Succinate Dehydrogenase A- Related Metastatic Pheochromocytoma and Paraganglioma.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3886, doi. 10.3390/cancers14163886
- By:
- Publication type:
- Article
Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.936178
- By:
- Publication type:
- Article
Choice is good at times: the emergence of [ <sup>64</sup>Cu]Cu-DOTATATE based somatostatin receptor imaging in the era of [ <sup>64</sup>Ga]Ga-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264183
- By:
- Publication type:
- Article
Choice is good at times: the emergence of [<sup>64</sup>Cu]Cu-DOTATATE based somatostatin receptor imaging in the era of [<sup>68</sup>Ga]Ga-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264183
- By:
- Publication type:
- Article
Personalized Management of Pheochromocytoma and Paraganglioma.
- Published in:
- Endocrine Reviews, 2022, v. 43, n. 2, p. 199, doi. 10.1210/endrev/bnab019
- By:
- Publication type:
- Article
Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 2, p. 385, doi. 10.1007/s00345-021-03851-x
- By:
- Publication type:
- Article
Correction to: Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A long noncoding RNA–microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.
- Published in:
- Endocrine (1355008X), 2022, v. 75, n. 1, p. 244, doi. 10.1007/s12020-021-02857-0
- By:
- Publication type:
- Article
Titanium-oxide activity during the formation of gold-bearing quartz veins: evidence for closed system behavior.
- Published in:
- Journal of Geosciences, 2022, v. 67, n. 1, p. 19, doi. 10.3190/jgeosci.340
- By:
- Publication type:
- Article
Intravitreous treatment of severe ocular von Hippel–Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: Results from a phase 1/2 clinical trial.
- Published in:
- Clinical & Experimental Ophthalmology, 2021, v. 49, n. 9, p. 1048, doi. 10.1111/ceo.14001
- By:
- Publication type:
- Article
Imaging of small intestine neuroendocrine neoplasms: Is SSTR PET the holy grail?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262140
- By:
- Publication type:
- Article
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3303, doi. 10.1007/s00262-021-02920-9
- By:
- Publication type:
- Article
Imaging of small intestine neuroendocrine neoplasms: Is SSTR PET the holy grail?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262140
- By:
- Publication type:
- Article
Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity.
- Published in:
- Molecules, 2021, v. 26, n. 21, p. 6567, doi. 10.3390/molecules26216567
- By:
- Publication type:
- Article